Benzinga | Mar 8, 2021 04:07PM EST

Castle Biosciences Q4 EPS $(0.23) Misses $(0.12) Estimate, Sales $17.30M Beat $15.74M Estimate

Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.12) by 91.67 percent. This is a 309.09 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $17.30 million which beat the analyst consensus estimate of $15.74 million by 9.91 percent. This is a 1.90 percent decrease over sales of $17.64 million the same period last year.